Illumina Ventures — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Heptahepta.bioinNov 2025 · $6.7M
Hepta develops LiquidTransformer, an AI platform for analyzing cell-free DNA fragments in blood to detect chronic disease molecular signals.
AI & Machine LearningBiotechHealthtechSan Francisco, US
Hamed Amini(Founder)inSoheil Damangir(Founder)
Co-investorsAlumni VenturesAME Cloud VenturesFelicis VenturesSeaX Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.